Growth factor receptor-protein bound 2 (GRB2) upregulation in the placenta in preeclampsia implies a possible role for ras signalling

被引:9
作者
Anteby, EY
Ayesh, S
Shochina, M
Hamani, Y
Schneider, T
Al-Shareef, W
Hochberg, A
Ariel, I
机构
[1] Hadassah Univ Hosp, Dept Pathol, IL-91240 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91240 Jerusalem, Israel
[3] Hadassah Univ Hosp, Dept Obstet & Gynecol, IL-91240 Jerusalem, Israel
[4] Hebrew Univ Jerusalem, Dept Biol Chem, Inst Life Sci, IL-91904 Jerusalem, Israel
[5] Hadassah Univ Hosp, Dept Rehabil, IL-91240 Jerusalem, Israel
[6] Makassed Islam Charitable Hosp, IL-91194 Jerusalem, Israel
关键词
gene expression profile; growth factor receptor bound-protein 2 (GRB2); intrauterine growth restriction; microarray; preeclampsia;
D O I
10.1016/j.ejogrb.2004.04.029
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To screen for genes with altered expression in placentas from pregnancies complicated by preeclampsia. Study design: To corroborate gene expression profile of preeclamptic and normal placentas (ATLAS((TM)) Clontech), by dot blot, Northern blot analysis and RTPCR for growth factor receptor bound-protein 2 (GRB2), using immunohistochemistry to localize its expression in the placenta. Results: Increased expression of GRB2 upregulated in the microarrays was found in preeclampsia by Dot blot and Northern blot analysis. RT-PCR performed with primers specific for GRB2 and its alternatively spliced isoform GRB3-3 showed that most of the cDNA represented in the array was GRB2. The protein was localized to the smooth muscle wall of stem vessels by immunohistochemistry. Conclusion: The ras signalling activated by placental receptor tyrosine kinases may play a role in the segmental thickening of the stem vascular wall in preeclamptic placentas, resulting in reduced blood flow to the developing fetus. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:174 / 181
页数:8
相关论文
共 27 条
[1]  
Abu-Amero SN, 1998, MOL REPROD DEV, V49, P229, DOI 10.1002/(SICI)1098-2795(199803)49:3<229::AID-MRD2>3.0.CO
[2]  
2-Q
[3]   Placental apoptosis in preeclampsia [J].
Allaire, AD ;
Ballenger, KA ;
Wells, SR ;
McMahon, MJ ;
Lessey, BA .
OBSTETRICS AND GYNECOLOGY, 2000, 96 (02) :271-276
[4]  
BROSENS IA, 1988, TROPHOBLAST RES, V3, P61
[5]   Proliferative effect of insulin on cultured smooth muscle cells from rat mesenteric resistance vessels [J].
Cruzado, M ;
Risler, N ;
Castro, C ;
Ortiz, A ;
Rüttler, ME .
AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (01) :54-58
[6]   Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells [J].
Eguchi, S ;
Iwasaki, H ;
Inagami, T ;
Numaguchi, K ;
Yamakawa, T ;
Motley, ED ;
Owada, KM ;
Marumo, F ;
Hirata, Y .
HYPERTENSION, 1999, 33 (01) :201-206
[7]  
ERSKINE RLA, 1985, BRIT J OBSTET GYNAEC, V92, P605
[8]   CLONING OF A GRB2 ISOFORM WITH APOPTOTIC PROPERTIES [J].
FATH, I ;
SCHWEIGHOFFER, F ;
REY, I ;
MULTON, MC ;
BOIZIAU, J ;
DUCHESNE, M ;
TOCQUE, B .
SCIENCE, 1994, 264 (5161) :971-974
[9]   Altered mRNA expression pattern of placental epidermal growth factor receptor (EGFR) in pregnancies complicated by preeclampsia and/or intrauterine growth retardation [J].
Faxén, M ;
Nasiell, J ;
Blanck, A ;
Nisell, H ;
Lunell, NO .
AMERICAN JOURNAL OF PERINATOLOGY, 1998, 15 (01) :9-13
[10]   Invasive cytotrophoblast apoptosis in pre-eclampsia [J].
Genbacev, O ;
DiFederico, E ;
McMaster, M ;
Fisher, SJ .
HUMAN REPRODUCTION, 1999, 14 :59-66